Your browser doesn't support javascript.
loading
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.
Chan, Wei Yee; Counsell, Nicholas; de Tute, Ruth; De-Silva, Dunnya; Phillips, Elizabeth H; Cavenagh, Jamie; Adedayo, Toyin; Braganca, Nivette; Roddie, Claire; Streetly, Matthew; Schey, Stephen; Koh, Mickey B C; Crowe, Josephine; Morris, Treen C; Cook, Gordon; Clifton-Hadley, Laura; Rabin, Neil; Owen, Roger G; Popat, Rakesh; Yong, Kwee L.
Afiliação
  • Chan WY; University College London Hospitals NHS Foundation Trust, London, UK.
  • Counsell N; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • de Tute R; Leeds Teaching Hospitals NHS Trust, London, UK.
  • De-Silva D; UCL Cancer Institute, London, UK.
  • Phillips EH; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Cavenagh J; Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester, UK.
  • Adedayo T; St. Bartholomew's Hospital, London, UK.
  • Braganca N; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Roddie C; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Streetly M; University College London Hospitals NHS Foundation Trust, London, UK.
  • Schey S; UCL Cancer Institute, London, UK.
  • Koh MBC; Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK.
  • Crowe J; Kings College London Hospital, London, UK.
  • Morris TC; St George's Hospital, London, UK.
  • Cook G; Royal United Hospital, Bath, UK.
  • Clifton-Hadley L; Belfast Trust, Belfast, UK.
  • Rabin N; Leeds Cancer Centre and Leeds Institute of Clinical Trials Research, Leeds, UK.
  • Owen RG; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Popat R; University College London Hospitals NHS Foundation Trust, London, UK.
  • Yong KL; Leeds Teaching Hospitals NHS Trust, London, UK.
Br J Haematol ; 196(4): e33-e37, 2022 02.
Article em En | MEDLINE | ID: mdl-34636043
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / Doxorrubicina / Bortezomib / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / Doxorrubicina / Bortezomib / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido